// App-Quantinova.ai

e14723 : Sorafenib (S) for hepatocellular carcinoma (HCC) treatment: Russian experience in cirrhotic (C) and non-cirrhotic (non-C) patients.

Researchers

Presenter

  • Valeriy Vladimirovich Breder

Principal Investigators

  • Yulia Bisovskaya

  • Svetlana Victorovna Khokhlova

  • Vera Gorbunova

Medical Centers

  • N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

  • N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia

  • Russian Cancer Research Centre n.a.N.Blokhin, Moscow, Russia

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved